Caffeic acid (CA) is a polyphenol that can be found in a wide range of vegetal dietary sources. It presents a remarkable antioxidant potential, but what is more interesting from the therapeutic point of view is, that it has demonstrated in vitro antimicrobial properties. Folliculitis is a common skin condition, usually caused by a bacterial or fungal infection, in which hair follicles become inflamed. A typical challenge in dermal application when the actives diffuse passively through the skin in a quick manner, as it is the case of CA, is to provide the effective concentration of the compound at the target site for the sufficient time to finalize the treatment adequately and reduce the possibility to trigger systemic side effects. To achieve this goal, it is necessary to appropriately design the drug delivery system. In this case, we leverage the ability of microparticles to accumulate into the hair follicles to design O/W-emulsions containing CA-loaded controlled-release microparticles. Two different emulsion types containing CA were prepared, one containing free CA and the other containing microencapsulated CA. Traditional and differential tape stripping techniques were performed to investigate drug distribution within the different skin layers and into the hair follicles. The Tape stripping results demonstrated that the tapes S3-S5 and S6-S10 presented a higher total amount of CA. The strips are collected and extracted in groups to assure the extraction of quantifiable amounts of drug. Samples S11-15 and S16-20 show a decrease in the amount of quantified CA, as it was expected. Thus, it can be seen that the amount of active decreases while the stratum corneum depth increases. The retention studies demonstrated that, the microparticles tend to produce a more homogeneous distribution of CA, within the stratum corneum and a higher retention into the hair follicle, which can be attributed to their size and uniformity. Besides, MPs present an additional advantage because they guarantee a continuous release of CA in the target for a prolonged period, allowing the treatment of folliculitis with a single dose until the MPs are removed from the hair follicle by its natural regeneration process or particle depletion of CA.
Vitamins are widely found in nature, for example, in plants and fruits. Ascorbic acid and nicotinamide are examples of these compounds that have potent antioxidant properties, besides stimulating collagen production and depigmenting properties that protect the skin from premature aging. To overcome the skin barrier and reduce the instability of antioxidant compounds, alternative systems have been developed to facilitate the delivery of antioxidants, making them efficiently available to the tissue for an extended time without causing damage or toxicity. The objective of this study was to obtain chitosan biodegradable microparticles containing ascorbic acid and nicotinamide for topical delivery. The microparticles were obtained by spray drying and characterized chemically by means of scanning electron microscopy, infrared spectroscopy, X-ray diffraction, and differential exploratory calorimetry. The drugs were successfully encapsulated and the microparticles showed positive zeta potential. In vitro release assays showed a sustained release profile. The evaluation of ex vivo skin permeation and retention demonstrated low permeation and adequate retention of the compounds in the epidermis/dermis, suggesting the efficient delivery from the obtained microparticles. Antibacterial assays have shown that microparticles can inhibit the growth of microorganisms in a time- and dose-dependent manner, corroborating their use in cosmetic products for application on the skin.
2 August 2016 in Journal of Dispersion Science and Technology
Ascorbic acid (AA) is involved in important metabolic processes in the human body. However, its chemical instability requires the assessment of products containing AA. The aim of this study was to develop systems that improve AA stability and to evaluate its release profile, permeation, and skin retention in vitro. For this purpose, we prepared binary systems consisting of propylene glycol and water, microemulsions, liquid crystalline systems, and an emulsion. The AA content in these systems was evaluated over time by measuring the inhibition of 1,1-diphenyl-2-picrylhydrazyl (DPPH). Our results demonstrated that the binary systems and molecular aggregates were less stable and effective than the emulsion. Thus, in vitro AA release, skin permeation, and retention were evaluated using the emulsion. Our results indicate that AA exhibits low release and permeation levels and a high retention rate in the skin, characteristics desirable in cosmetic products. GRAPHICAL ABSTRACT